Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers

Marion Dietrich, Gladys Block, Mark Hudes, Jason D. Morrow, Edward P. Norkus, Maret G. Traber, Carroll E Cross, Lester Packer

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Free radicals in cigarette smoke (CS) cause oxidative damage to proteins, DNA, and lipids, contributing to the pathobiology of atherosclerosis, heart disease, and cancer. In vitro studies have shown that antioxidants quench free radicals and ameliorate certain aspects of biomolecular damage caused by CS. It is hypothesized that a combination of antioxidants is more effective than a single antioxidant, due to their interactions. To investigate whether supplemental antioxidants reduce CS-related lipid peroxidation in vivo and whether they are more effective in combination, we conducted an intervention study in smokers. In a randomized doubleblind placebo-controlled trial, we investigated whether vitamin C or an antioxidant mixture containing vitamin C, α-lipoic acid, and vitamin E decreases plasma F2-isoprostane levels, an index of oxidant stress, in smokers. Plasma of 126 smokers (mean age, 46 years; age range, 20-78 years) was analyzed for F2-isoprostanes at baseline and after intervention with antioxidants and placebo. In smokers with a body mass index (BMI) above the median, 2 months of daily supplementation with 500 mg of vitamin C decreased plasma F2-isoprostane levels by 28.8 pmol/liter when compared with the placebo group (P = 0.001); levels in the mixture group were 7.45 pmol/liter lower after treatment, but this difference was not statistically significant (P = 0.14). There was no treatment effect in smokers with a low BMI. BMI was significantly positively associated with plasma F2-isoprostane levels (trend P = 0.001). Antioxidants decrease smoking-related lipid peroxidation markers of oxidative stress in humans with high BMI. Our results do not indicate that an antioxidant combination is more effective than vitamin C alone. The intake of antioxidants may help prevent smoking-related diseases. Smoking cessation should still be considered the most effective way to prevent smoking-related diseases.

Original languageEnglish (US)
Pages (from-to)7-13
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume11
Issue number1
StatePublished - 2002

Fingerprint

F2-Isoprostanes
Lipid Peroxidation
Antioxidants
Biomarkers
Ascorbic Acid
Body Mass Index
Smoke
Tobacco Products
Smoking
Placebos
Free Radicals
Thioctic Acid
Heart Neoplasms
Smoking Cessation
Vitamin E
Oxidants
Heart Diseases
Atherosclerosis
Oxidative Stress

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Dietrich, M., Block, G., Hudes, M., Morrow, J. D., Norkus, E. P., Traber, M. G., ... Packer, L. (2002). Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers. Cancer Epidemiology Biomarkers and Prevention, 11(1), 7-13.

Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers. / Dietrich, Marion; Block, Gladys; Hudes, Mark; Morrow, Jason D.; Norkus, Edward P.; Traber, Maret G.; Cross, Carroll E; Packer, Lester.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 11, No. 1, 2002, p. 7-13.

Research output: Contribution to journalArticle

Dietrich, M, Block, G, Hudes, M, Morrow, JD, Norkus, EP, Traber, MG, Cross, CE & Packer, L 2002, 'Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers', Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 1, pp. 7-13.
Dietrich, Marion ; Block, Gladys ; Hudes, Mark ; Morrow, Jason D. ; Norkus, Edward P. ; Traber, Maret G. ; Cross, Carroll E ; Packer, Lester. / Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers. In: Cancer Epidemiology Biomarkers and Prevention. 2002 ; Vol. 11, No. 1. pp. 7-13.
@article{eaaa9b26faf146c6b5f394613e040145,
title = "Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers",
abstract = "Free radicals in cigarette smoke (CS) cause oxidative damage to proteins, DNA, and lipids, contributing to the pathobiology of atherosclerosis, heart disease, and cancer. In vitro studies have shown that antioxidants quench free radicals and ameliorate certain aspects of biomolecular damage caused by CS. It is hypothesized that a combination of antioxidants is more effective than a single antioxidant, due to their interactions. To investigate whether supplemental antioxidants reduce CS-related lipid peroxidation in vivo and whether they are more effective in combination, we conducted an intervention study in smokers. In a randomized doubleblind placebo-controlled trial, we investigated whether vitamin C or an antioxidant mixture containing vitamin C, α-lipoic acid, and vitamin E decreases plasma F2-isoprostane levels, an index of oxidant stress, in smokers. Plasma of 126 smokers (mean age, 46 years; age range, 20-78 years) was analyzed for F2-isoprostanes at baseline and after intervention with antioxidants and placebo. In smokers with a body mass index (BMI) above the median, 2 months of daily supplementation with 500 mg of vitamin C decreased plasma F2-isoprostane levels by 28.8 pmol/liter when compared with the placebo group (P = 0.001); levels in the mixture group were 7.45 pmol/liter lower after treatment, but this difference was not statistically significant (P = 0.14). There was no treatment effect in smokers with a low BMI. BMI was significantly positively associated with plasma F2-isoprostane levels (trend P = 0.001). Antioxidants decrease smoking-related lipid peroxidation markers of oxidative stress in humans with high BMI. Our results do not indicate that an antioxidant combination is more effective than vitamin C alone. The intake of antioxidants may help prevent smoking-related diseases. Smoking cessation should still be considered the most effective way to prevent smoking-related diseases.",
author = "Marion Dietrich and Gladys Block and Mark Hudes and Morrow, {Jason D.} and Norkus, {Edward P.} and Traber, {Maret G.} and Cross, {Carroll E} and Lester Packer",
year = "2002",
language = "English (US)",
volume = "11",
pages = "7--13",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers

AU - Dietrich, Marion

AU - Block, Gladys

AU - Hudes, Mark

AU - Morrow, Jason D.

AU - Norkus, Edward P.

AU - Traber, Maret G.

AU - Cross, Carroll E

AU - Packer, Lester

PY - 2002

Y1 - 2002

N2 - Free radicals in cigarette smoke (CS) cause oxidative damage to proteins, DNA, and lipids, contributing to the pathobiology of atherosclerosis, heart disease, and cancer. In vitro studies have shown that antioxidants quench free radicals and ameliorate certain aspects of biomolecular damage caused by CS. It is hypothesized that a combination of antioxidants is more effective than a single antioxidant, due to their interactions. To investigate whether supplemental antioxidants reduce CS-related lipid peroxidation in vivo and whether they are more effective in combination, we conducted an intervention study in smokers. In a randomized doubleblind placebo-controlled trial, we investigated whether vitamin C or an antioxidant mixture containing vitamin C, α-lipoic acid, and vitamin E decreases plasma F2-isoprostane levels, an index of oxidant stress, in smokers. Plasma of 126 smokers (mean age, 46 years; age range, 20-78 years) was analyzed for F2-isoprostanes at baseline and after intervention with antioxidants and placebo. In smokers with a body mass index (BMI) above the median, 2 months of daily supplementation with 500 mg of vitamin C decreased plasma F2-isoprostane levels by 28.8 pmol/liter when compared with the placebo group (P = 0.001); levels in the mixture group were 7.45 pmol/liter lower after treatment, but this difference was not statistically significant (P = 0.14). There was no treatment effect in smokers with a low BMI. BMI was significantly positively associated with plasma F2-isoprostane levels (trend P = 0.001). Antioxidants decrease smoking-related lipid peroxidation markers of oxidative stress in humans with high BMI. Our results do not indicate that an antioxidant combination is more effective than vitamin C alone. The intake of antioxidants may help prevent smoking-related diseases. Smoking cessation should still be considered the most effective way to prevent smoking-related diseases.

AB - Free radicals in cigarette smoke (CS) cause oxidative damage to proteins, DNA, and lipids, contributing to the pathobiology of atherosclerosis, heart disease, and cancer. In vitro studies have shown that antioxidants quench free radicals and ameliorate certain aspects of biomolecular damage caused by CS. It is hypothesized that a combination of antioxidants is more effective than a single antioxidant, due to their interactions. To investigate whether supplemental antioxidants reduce CS-related lipid peroxidation in vivo and whether they are more effective in combination, we conducted an intervention study in smokers. In a randomized doubleblind placebo-controlled trial, we investigated whether vitamin C or an antioxidant mixture containing vitamin C, α-lipoic acid, and vitamin E decreases plasma F2-isoprostane levels, an index of oxidant stress, in smokers. Plasma of 126 smokers (mean age, 46 years; age range, 20-78 years) was analyzed for F2-isoprostanes at baseline and after intervention with antioxidants and placebo. In smokers with a body mass index (BMI) above the median, 2 months of daily supplementation with 500 mg of vitamin C decreased plasma F2-isoprostane levels by 28.8 pmol/liter when compared with the placebo group (P = 0.001); levels in the mixture group were 7.45 pmol/liter lower after treatment, but this difference was not statistically significant (P = 0.14). There was no treatment effect in smokers with a low BMI. BMI was significantly positively associated with plasma F2-isoprostane levels (trend P = 0.001). Antioxidants decrease smoking-related lipid peroxidation markers of oxidative stress in humans with high BMI. Our results do not indicate that an antioxidant combination is more effective than vitamin C alone. The intake of antioxidants may help prevent smoking-related diseases. Smoking cessation should still be considered the most effective way to prevent smoking-related diseases.

UR - http://www.scopus.com/inward/record.url?scp=0036165425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036165425&partnerID=8YFLogxK

M3 - Article

C2 - 11815395

AN - SCOPUS:0036165425

VL - 11

SP - 7

EP - 13

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -